HealthStream (NASDAQ:HSTM) Stock Rating Lowered by Wall Street Zen

HealthStream (NASDAQ:HSTM) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Sunday, Wall Street Zen reports.

Other equities research analysts also recently issued research reports about the stock. Craig Hallum downgraded shares of HealthStream from a “buy” rating to a “hold” rating and set a $40.00 target price for the company. in a research report on Tuesday, November 3rd. Weiss Ratings raised shares of HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Freedom Capital upgraded HealthStream to a “hold” rating in a research note on Tuesday, October 13th. Canaccord Genuity Group lifted their price objective on shares of HealthStream from $29.00 to $32.00 and gave the company a “hold” rating in a research report on Wednesday, November 4th. Finally, Citigroup reaffirmed a “market perform” rating on shares of HealthStream in a report on Tuesday, October 27th. One research analyst has rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $36.00.

HealthStream Stock Performance

HSTM stock opened at $28.85 on Friday. HealthStream has a fifty-two week low of $19.50 and a fifty-two week high of $35.60. The business’s 50 day moving average price is $31.19 and its two-hundred day moving average price is $25.87. The company has a market capitalization of $843.00 million, a price-to-earnings ratio of 41.21, a price-to-earnings-growth ratio of 3.76 and a beta of 0.45.

HealthStream (NASDAQ:HSTM) last issued its quarterly earnings results on Monday, November 2nd. The technology company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.02. The company had revenue of $83.31 million during the quarter, compared to analysts’ expectations of $82.24 million. HealthStream had a net margin of 6.25% and a return on equity of 6.37%. Sell-side analysts forecast that HealthStream will post 0.80 earnings per share for the current year.

Insider Buying and Selling at HealthStream

In related news, Director Linda Rebrovick sold 12,000 shares of the stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $35.00, for a total transaction of $420,000.00. Following the completion of the sale, the director owned 39,329 shares of the company’s stock, valued at $1,376,515. This represents a 23.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Deborah Tate sold 3,281 shares of the stock in a transaction that occurred on Thursday, November 5th. The shares were sold at an average price of $32.19, for a total transaction of $105,615.39. Following the sale, the director directly owned 21,418 shares of the company’s stock, valued at $689,445.42. The trade was a 13.28% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 194,149 shares of company stock valued at $5,844,892. 20.40% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On HealthStream

A number of large investors have recently made changes to their positions in HSTM. BlackRock Inc. purchased a new stake in shares of HealthStream during the 2nd quarter valued at $111,184,000. Dimensional Fund Advisors LP grew its stake in shares of HealthStream by 6.4% during the first quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock worth $30,156,000 after acquiring an additional 87,177 shares during the last quarter. Copeland Capital Management LLC grew its stake in shares of HealthStream by 43.8% during the first quarter. Copeland Capital Management LLC now owns 1,276,739 shares of the technology company’s stock worth $26,441,000 after acquiring an additional 389,186 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of HealthStream by 0.5% during the first quarter. Renaissance Technologies LLC now owns 477,848 shares of the technology company’s stock worth $9,896,000 after acquiring an additional 2,380 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its stake in shares of HealthStream by 21.1% during the first quarter. Arrowstreet Capital Limited Partnership now owns 377,945 shares of the technology company’s stock worth $7,827,000 after acquiring an additional 65,806 shares during the last quarter. 69.58% of the stock is owned by institutional investors and hedge funds.

HealthStream Company Profile

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.

The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.